ImageneBio (IMA) EBITDA Margin Growth (1y) (2021 - 2024)
ImageneBio (IMA) EBITDA Margin Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | -1,651.00 |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 158,765.00 |
| Dec 31, 2023 | -304,711.00 |
| Sep 30, 2023 | -136,660.00 |
| Jun 30, 2023 | 456,190.00 |
| Mar 31, 2023 | 20,922.00 |
| Dec 31, 2022 | -29,113.00 |
| Sep 30, 2022 | 10,844.00 |
| Jun 30, 2022 | -512,707.00 |
| Mar 31, 2022 | -22,145.00 |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | -16,734.00 |
| Jun 30, 2021 | -19,285.00 |
| Mar 31, 2021 | -5,742.00 |